Indicated for: nasal congestion; rhinitis
Route of administration: injectable
Substance: tropicamide + phenylephrine + lidocaine (mydriatic + adrenergic decongestant + local anesthetic)
ATC: S01FA56 (Sensory organs | Mydriatics and cycloplegics | Anticholinergics)
Tropicamide+phenylephrine+lidocaine is a combination of medications used in ophthalmology for pupil dilation (mydriasis) and local anesthesia during diagnostic or surgical procedures. Tropicamide is a muscarinic receptor antagonist that relaxes the iris muscles, phenylephrine is an alpha-adrenergic agonist that contracts the iris dilator muscles, and lidocaine is a local anesthetic that reduces pain.
This combination is administered as ophthalmic drops, as directed by a physician. It is commonly used in fundus examinations, cataract surgery, or other ophthalmic interventions.
Common side effects include a burning or stinging sensation in the eye, dry eyes, and temporary photophobia. In rare cases, allergic reactions or temporary increases in intraocular pressure may occur.
Tropicamide+phenylephrine+lidocaine is an effective and safe combination for use in ophthalmology, helping to improve patient comfort and facilitate medical procedures.